» Authors » Ann K Rosenthal

Ann K Rosenthal

Explore the profile of Ann K Rosenthal including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 51
Citations 809
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Mirza M, Fernandes A, Sherman K, Rosenthal A
Semin Arthritis Rheum . 2025 Feb; 71:152641. PMID: 39893939
Background/objective: Calcium pyrophosphate deposition disease (CPPD) is a type of arthritis affecting aging adults that presents with chronic and acute inflammatory and non-inflammatory joint disease. While the etiology of CPPD...
2.
Rosenthal A, Csuka M, Halverson P
Rheum Dis Clin North Am . 2023 Nov; 50(1):15-23. PMID: 37973282
There is no doubt that Dr Daniel J McCarty warrants inclusion among the giants of rheumatology. He has made major contributions to both clinical and scientific knowledge in our field,...
3.
Mitton-Fitzgerald E, Gohr C, Williams C, Rosenthal A
Curr Rheumatol Rep . 2022 Feb; 24(2):40-45. PMID: 35143028
Objectives: Arthritis is a common clinical manifestation of hereditary hemochromatosis (HH), and HH is one of a handful of conditions linked to calcium pyrophosphate deposition (CPPD) in joints. The connection...
4.
Williams C, Rosenthal A
Best Pract Res Clin Rheumatol . 2021 Oct; 35(4):101718. PMID: 34696986
Calcium pyrophosphate deposition disease is defined by the presence of calcium pyrophosphate (CPP) crystals in articular cartilage and is the fourth most common type of arthritis in adults. Despite its...
5.
Zell M, Aung T, Kaldas M, Rosenthal A, Bai B, Liu T, et al.
Osteoarthr Cartil Open . 2021 Aug; 3(1). PMID: 34386778
Objective: To describe the characteristics of calcium pyrophosphate (CPP) crystal size and morphology under compensated polarized light microscopy (CPLM). Secondarily, to describe CPP crystals seen only with digital enhancement of...
6.
Cai K, Fuller A, Zhang Y, Hensey O, Grossberg D, Christensen R, et al.
Semin Arthritis Rheum . 2021 Jun; 51(4):946-950. PMID: 34140183
Introduction: Although calcium pyrophosphate deposition (CPPD) is common, there are no published outcome domains or validated measurement instruments for CPPD studies. In this paper, we describe the framework for development...
7.
Rosenthal A
Cleve Clin J Med . 2021 Apr; 88(4):206-207. PMID: 33795241
No abstract available.
8.
Kolarz B, Ciesla M, Rosenthal A, Dryglewska M, Majdan M
Ther Adv Musculoskelet Dis . 2021 Feb; 13:1759720X21989868. PMID: 33628335
Background: Anti-citrullinated protein antibodies (ACPAs) and rheumatoid factor (RF) are key factors in the American College of Rheumatology/European League Against Rheumatism rheumatoid arthritis (RA) classification criteria markers. However, about 30%...
9.
Mitton-Fitzgerald E, Gohr C, Williams C, Ortiz A, Mbalaviele G, Rosenthal A
Arthritis Rheumatol . 2021 Feb; 73(8):1543-1549. PMID: 33559312
Objective: The gene TNFRSF11B encodes for osteoprotegerin (OPG) and was recently identified as the CCAL1 locus associated with familial calcium pyrophosphate deposition disease (CPDD). While the CCAL1 OPG mutation (OPG-XL)...
10.
Parperis K, Papachristodoulou E, Kakoullis L, Rosenthal A
Semin Arthritis Rheum . 2020 Dec; 51(1):84-94. PMID: 33360232
Objective: Calcium pyrophosphate crystal deposition disease (CPPD) is a common cause of acute and chronic arthritis, especially in the elderly population. There is a paucity of data regarding the management...